Biden has proposed a $9 billion increase in funding for the National Institutes of Health (NIH), of which $6.5 billion will be earmarked for a new funding institute to be called ARPA-H (Advanced Research Projects Agency – Health).
Several organizations, both providers and payers, have pledged to help the White House achieve its goal of administering at least one dose of the Covid-19 vaccine to 70% of Americans over the next month. These organizations are launching various initiatives to engage the unvaccinated, including call campaigns and financial incentives.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of Climate Change and Health Equity.
With the Democrats leading the Senate and House, and Joe Biden installed as president, the Affordable Care Act will be restored and strengthened over the next four years, an expert from the Kaiser Family Foundation predicts.
President-elect Joe Biden named Xavier Becerra, the current California attorney general, as his nominee for HHS secretary. A 12-term congressman and vocal supporter of the ACA, Becerra would become the first Latino to lead the federal agency if confirmed.
The announcement came as the candidate announced his own healthcare policy proposals, which seeks to build on existing provisions in the Affordable Care Act, while opening up a new public option for coverage.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Biden Cancer Initiative has announced that multiple healthcare organizations — including BreastCancerTrials.org, IBM Watson Health, Massive Bio and Syapse — are creating a shared platform called the Oncology Clinical Trial Information Commons, which will help cancer patients to know their clinical trial options.
"Unfortunately, the announcement lacked many specific actions to effectively implement the initiative," Biden wrote in a Forbes commentary. "I agree with the administration's stated goals, but real action is needed — and now is the time."
In his second successive appearance at the annual StartUp Health Festival in San Francisco, Tuesday, Biden expresses anger, frustration, grief but also hope about the healthcare system.
What would happen if we attacked cancer from an agnostic, 10,000-foot point of view? As president of the Biden Cancer Initiative, Greg Simon is determined to find out.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In 12 months, the Cancer Moonshot has made great strides, secured $1.8 billion in funding and seeded countless projects, partnerships, and possibilities. One year on, a new administration has the power to undo it all.
The idea is to showcase the Philadelphia region as a hub of healthcare innovation that can, among other things, help Biden's Cancer Moonshot effort.
From Vinod Khosla's talk about the healthcare startups he loves to hate to Illumina and IBM's partnership, here are the most noteworthy stories to emerge from the rain-soaked J.P. Morgan Healthcare conference and the satellite events around it.
In San Francisco during J.P. Morgan week, the vice president called for the end to a siloed healthcare system to help accelerate the battle against cancer and announced what he will do after his tenure in public office ends.
Among the highlights of Wednesday's Cancer Moonshot Summit was news that IBM Watson Health will team with the U.S. Department of Veterans Affairs to bring precision medicine to 10,000 veterans with cancer over the next two years.